- Raman Spectroscopy
- MIR/NIR (Mid/Near Infrared Spectroscopy)
- Optical Coherence Tomography
- Occlusion Spectroscopy
- Thermal Emission Spectroscopy
- Impedance/Dielectric Spectroscopy
- Photoacoustic Spectroscopy
- Electromagnetic
- Fluorescence
- Polarimetry
Non-Invasive Glucose Monitoring Devices Market size was valued at USD 15 million in 2021 and is expected to reach USD 94.1 million by 2028 growing at a CAGR of 30% from 2022-2028. The non-Invasive Glucose Monitoring Devices Market has many market players and highly fragmented. Market players invest on product innovations to sustain their position in the market. In addition collaborations and acquisitions are key strategies used by market players to increase their market share. For example in 2014, NovioSense had created smaller than usual electrochemical sensor that empower non-obtrusive glucose checking and is equipped for identifying glucose focus in human tears. Technological progressions and expanding FDA endorsement for observing gadgets is required to give lucrative development chances to showcase players in coming years. For example, the advancement of new checking gadgets, for example, GlucoTrack which is a non-obtrusive blood glucose screen that clasps to ear cartilage consequently disposing of the requirement for day by day finger pricks.Systemic Lupus Erythematosus (SLE) is an immune system infection that influences different organ frameworks of the body, and its side effects go from general disquietude to genuine, CNS and renal indications. Presently, there are restricted treatment choices accessible to treat the condition. Corticosteroids, hydroxychloroquine, and ordinary immunosuppressant are the pillar of treatment for SLE. Non-Invasive Blood Glucose Monitoring Devices use a painless approach to track a patient's glucose level on a continuous basis. Non-invasive blood glucose monitoring devices require fewer finger sticks and allow data to be easily transferred and shared for further analysis. Patients can use these gadgets at home to monitor their blood glucose levels. Noninvasive glucose monitoring reduces the necessity for unpleasant pricking, which increases the risk of infection and the amount of damage to finger tissue.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Non-Invasive Glucose Monitoring Devices market is driven by high incidence of diabetes worldwide. According to WHO, prevalence of diabetes among adults over 18 years of age to have risen from 4.7% in 2012 to 8.5% by 2014. It also projects high blood glucose level and diabetes to be the 7th leading cause of death in 2030. In addition technological advancements in glucose measuring devices such as evolution of continuous glucose monitoring devices are propelling the growth of Non-Invasive Glucose Monitoring Devices market. Furthermore increase in demand for portable self-glucose measuring devices, increase in R&D investment and government funding in prevention and treatment of diabetes are expected to bolster the Non-Invasive Glucose Monitoring Devices globally
The non-invasive glucose monitoring devices market is projected to expand at a CAGR of 30% during the forecast period.
Abbott Laboratories (U.S.), ARKRAY, Inc. (Japan), Bayer AG (Germany), Dexcom, Inc. (U.S.), Hoffmann-La Roche Ltd (Switzerland)
North America is the fastest-growing region for non-invasive glucose monitoring devices market